Britain's biggest company AstraZeneca has paused a planned 200 million pound ($271.26 million) investment in its Cambridge research site, a spokesperson said.
The decision on the investment, which had been set to create 1,000 jobs, means none of AstraZeneca's planned new funding – originally announced in March 2024 – is currently proceeding.